Pivot Bridge®
Our temporary, flow-aligned valve support for tricuspid regurgitation (TR) —
A minimally invasive, dynamic solution designed to stabilize
high-risk patients and prepare them for future therapies.
Pivot Bridge®
Device Summary: Pivot Bridge®
Intended Use
Pre-habilitation & diagnostic
(preparation for definitive therapy)
Target Disease
Secondary tricuspid regurgitation
TR Severity Treated
TR inclusive of massive & torrential cases
Target Population
High-risk, frail, or inoperable patients with severe TR
Implant Duration
Temporary (~up to 1 week)
Deployment Method
Transfemoral venous access / transcatheter
Removal
Removable and reversible by transcatheter retrieval, or manual removal at time of surgery
Anchoring
Atraumatic non-fixated anchoring (IVC + PA)
Spacer Design
Self-centering oblong spacer with flow apertures
Spacer Materials
ePTFE sheath, nitinol mesh frame
Valve Interaction
Supports leaflet coaptation without fixation or leaflet trauma
Flow Preservation
Spacer designed for hemodynamic flow through and around the device
Adaptability
Dynamic self-centering and adaptable to progressive cardiac remodeling
Procedural Setting
Percutaneous intervention; cath lab or hybrid OR
Customization
Bridge to surgery, transcatheter repair, or replacement options
Pivot Bridge® Delivery
Simple Transfemoral Approach
Pivot Bridge® is implanted through a transfemoral venous access using standard catheter techniques. The device is delivered via the femoral vein, navigated through the inferior vena cava (IVC) into the right atrium, and positioned across the tricuspid valve.
Once the delivery catheter is unsheathed, the obliquely oriented spacer deploys within the valve orifice, with atraumatic, non-fixated anchors engaging the pulmonary artery (PA) and IVC to hold the device in place. The delivery system is designed for rapid, fluoroscopy-guided placement with minimal reliance on advanced imaging. The procedure is quick, reversible, and well-suited to critically ill or frail patients requiring pre-operative stabilization.
Access Site
Transfemoral venous access
(standard percutaneous approach)
Delivery Path
Femoral vein → IVC → Right atrium → Pulmonary artery
Deployment Orientation
Oblique positioning across the tricuspid valve
Proximal Anchor
Distal Anchor
Spiral structure within the IVC
Atraumatic extension into the pulmonary artery
Spacer Design
ePTFE-covered nitinol mesh
Hemodynamic flow windows
Positioning
Self-centering within valve during systole
Imaging
Fluoroscopy-guided
No TEE or ICE required
Retrievability
Fully catheter-retrievable Designed for removal
Est. Procedure Time
~60 minutes
Learning Curve
Low; designed for rapid adoption by interventional teams